Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$16.44 - $37.73 $9.04 Million - $20.8 Million
-550,026 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$19.57 - $28.96 $5.84 Million - $8.65 Million
298,565 Added 118.73%
550,026 $15.2 Million
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $3.91 Million - $6.16 Million
145,133 Added 136.5%
251,461 $6.77 Million
Q2 2019

Aug 14, 2019

BUY
$18.54 - $40.97 $1.97 Million - $4.36 Million
106,328 New
106,328 $4.36 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.